Johnson & Johnson (JNJ) Stock Forecast & Price Prediction 2025, 2030, 2040, and 2050
Get detailed Johnson & Johnson (JNJ) stock forecast for 2025, monthly, along with long-term JNJ price prediction from 2025 to 2050. Look at historical stock performance, analyst recommendations (Buy, Sell, or Hold), and the latest Johnson & Johnson headlines.
1 Month Prediction
$294.24 [79.82%]
3 Month Prediction
$295.96 [80.87%]
6 Month Prediction
$311.22 [90.20%]
1 Year Prediction
$309.55 [89.17%]
3 Year Prediction
$314.63 [92.28%]
5 Year Prediction
$319.88 [95.49%]
About Johnson & Johnson
Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 by Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson. The company is headquartered in New Brunswick, New Jersey, and operates in over 60 countries with over 130,000 employees globally.
The company started by producing sterile surgical dressings and since then, it has expanded its operations to medical devices, pharmaceuticals, and consumer health products. J&J's main products include pharmaceuticals for immune diseases, cancer, neurological disorders, etc. Also, the company owns known consumer brands such as Band-Aid, Tylenol, and Aveeno.
Johnson & Johnson (JNJ) Historical Performance
IPO Date
Johnson & Johnson (NYSE:JNJ) went public on 24 September, 1944.
Change
Since inception, JNJ has increased by 17,220.52%. In the last 5 years, JNJ has risen from $130.40 to $163.63, a massive 25.49% increase since 2020.
Historical Highs and Lows
In the past 5 years, the stock reached a high of $165.16 and a low of $120.78.
52 Week Range
$140.68
$169.99
The current price $163.63 is near the 52-week high, which means that the stock is overbought.
JNJ Stock Price History
Based on JNJ stock's historical price data, this table shows how the stock has performed in the last 6 years. Since 2019, the JNJ stock has risen from $113.96 - $139.6 to $150.94 - $163.71, which is up 38.36%. Currently, the stock follows upward trend.
Here, we have calculated stock range of JNJ, indicating the highs and lows for each year, the average price based on the daily closing prices each year, and the change% from the average price.
| Year | Stock Price | Avg Price | Change% | Year Change |
|---|---|---|---|---|
| 2020 | $113.96 - $139.6 | $126.85 | 10.09 | 1 Year Change |
| 2021 | $140.56 - $155.57 | $147.99 | 28.44 | 2 Year Change |
| 2022 | $148.61 - $165.16 | $159.47 | 38.4 | 3 Year Change |
| 2023 | $141.51 - $158.67 | $149.82 | 30.02 | 4 Year Change |
| 2024 | $140.1 - $162.0 | $151.27 | 31.28 | 5 Year Change |
| 2025 | $150.94 - $163.71 | $159.43 | 38.36 | 6 Year Change |
JNJ Price Performance
6-Month Performance
JNJ stock jumped by 4.01% in the last six months.
1-Year Performance
The stock has trended upwards by 16.80% in the past year.
3-Year Performance
In the last 3 years, the stock has plummeted by 0.93%.
5-Year Performance
In the last 5 years, the stock has gone up by 25.49%.
According to Johnson & Johnson's historical data, below graph gives us the exact picture of how the JNJ stock has performed year-over-year. Here, Each bar on the graph represents a particular year that illustrates how the stock's price changed from one year to the next.
YoY Performance
In the last five years, the stock has shown positive growth in 3 years and a decline in 2 years.
2020
10.82% ↑
2021
11.44% ↑
2022
5.97% ↑
2023
8.58% ↓
2024
4.81% ↓
NOTE: Green bars indicate that the stock has risen compared to the previous year, while red bars show that the stock has fallen.
Johnson & Johnson (JNJ) Financials & Stock Analysis
Total Revenue
Quarterly Revenue: $22.52 B (Q4)
Revenue for Q4 ending 31st December, 2024 increased 0.22% compared to Q3 ending 30th September, 2024.
Annual Revenue: $88.82 B (1Y)
Revenue for trailing 12 months decreased 0.00% year over year from 31st December, 2024.
If compared to the last 4 years, the revenue has gone up from $78.74 billion to $88.82 billion, a 12.80% change.
Market Capitalization
Johnson & Johnson has a market capitalization of $394.32B, which places JNJ in the mega-cap category.
Fundamental Analysis
EPS: $1.43 (Q4), $5.84 (1Y)
EPS increased 27.38% since last quarter, and decreased 57.90% since last year.
Net Income: $3.43 B (Q4), $14.07 B (1Y)
Net Income increased 27.36% since last quarter, and decreased 59.99% since last year.
Free Cash Flow: $4.84 B (Q4), $18.06 B (1Y)
Free Cash Flow decreased 15.33% since last quarter, and increased 1.58% since last year.
Net Profit Margin: 15.24% (Q4), 15.84% (1Y)
Net Profit Margin increased 27.08% since last quarter, and decreased 59.99% since last year.
Below, we have listed 12 key indicators for Fundamental analysis for JNJ stock. These indicators help you understand Johnson & Johnson's financial health, earnings and growth potential, and make a decision if the stock is a good long-term investment or not.
|
|
Technical Analysis
Here, we have listed 5 key indicators for Technical Analysis for JNJ stock. These indicators help investors study past price movements and trading volumes to forecast future price changes, and find the right time when to buy, sell or hold the stock.
| Technical Indicators | Value |
|---|---|
| SMA20 | $164.55 |
| SMA50 | $156.00 |
| SMA200 | $153.65 |
| RSI | 36.23 |
| Beta | 0.46 |
SMA20 > Current Price
This signals JNJ stock is in short-term bearish momentum.
SMA50 < Current Price
This signals JNJ stock is in mid-term bullish momentum.
SMA200 < Current Price
This signals JNJ stock is in long-term bullish momentum.
Sentiment Based on Technical Analysis
Based on 8 technical analysis indicators, the overall sentiment for JNJ stock is Bullish. Out of all indicators, 5 indicates bullish signals, 1 signals bearish trends and 3 gives neutral trends. The JNJ stock forecast was last updated on 22 March, 2025.
Johnson & Johnson (JNJ) Stock Price Prediction and Forecast
According to short-term forecast, the stock is expected to rise to $305.97 by the end of 2025, and can reach around $282.82 to $311.34 in 2026. And, the long-term forecast suggests that the stock may further jump to $311.52 - $270.52 in 2028, and $313.12 - $300.51 by 2031. So, the JNJ stock shows a strong upward trend in the next several years.
Short-term JNJ Stock Price Prediction & Forecast
| Date | Forecasted Price | Change% |
|---|---|---|
| 2025-04 | $294.24 | 79.82% |
| 2025-05 | $295.45 | 80.56% |
| 2025-06 | $295.96 | 80.87% |
| 2025-07 | $307.41 | 87.87% |
| 2025-08 | $314.65 | 92.29% |
| 2025-09 | $311.22 | 90.2% |
| 2025-10 | $294.65 | 80.07% |
| 2025-11 | $301.66 | 84.35% |
| 2025-12 | $305.97 | 86.99% |
In 2025, the JNJ stock price is expected to fluctuate between $294.24 and $314.65. According to the monthly forecast, the stock could rise to $305.97 by December 2024. If compared to the JNJ's current price, the stock could gain 86.99% by the end of this year.
Long-term JNJ Stock Price Prediction & Forecast
| Year | Year Start | Year Mid | Year End | Change% |
|---|---|---|---|---|
| 2026 | $282.82 | $290.39 | $311.34 | 90.27% |
| 2027 | $320.50 | $335.84 | $316.75 | 93.58% |
| 2028 | $311.52 | $311.44 | $270.52 | 65.32% |
| 2029 | $319.12 | $341.05 | $297.22 | 81.64% |
| 2030 | $334.94 | $315.10 | $300.60 | 83.71% |
| 2031 | $313.12 | $305.05 | $300.51 | 83.65% |
| 2032 | $329.14 | $340.93 | $318.33 | 94.54% |
| 2033 | $300.37 | $344.05 | $318.78 | 94.82% |
| 2034 | $333.74 | $329.42 | $318.68 | 94.76% |
| 2035 | $331.23 | $352.74 | $345.40 | 111.09% |
| 2036 | $328.67 | $335.24 | $316.14 | 93.2% |
| 2037 | $334.72 | $350.59 | $333.58 | 103.86% |
| 2038 | $332.57 | $327.08 | $339.11 | 107.24% |
| 2039 | $340.94 | $343.22 | $346.32 | 111.65% |
| 2040 | $339.41 | $339.67 | $327.38 | 100.07% |
| 2041 | $340.69 | $313.86 | $329.70 | 101.49% |
| 2042 | $353.25 | $355.34 | $339.49 | 107.47% |
| 2043 | $352.78 | $353.43 | $338.44 | 106.83% |
| 2044 | $336.30 | $333.56 | $329.54 | 101.39% |
| 2045 | $337.99 | $365.71 | $350.84 | 114.41% |
| 2046 | $397.41 | $365.45 | $329.20 | 101.19% |
| 2047 | $341.03 | $337.96 | $351.63 | 114.89% |
| 2048 | $384.61 | $360.61 | $379.43 | 131.88% |
| 2049 | $383.22 | $394.01 | $344.05 | 110.26% |
| 2050 | $370.74 | $385.94 | $353.45 | 116.01% |
| 2051 | $344.76 | $394.12 | $377.84 | 130.91% |
Johnson & Johnson (JNJ) Stock Price Prediction & Forecast 2025
At the start of 2025, the JNJ stock was at $150.94. Today, it is trading at $163.63, which is 8.41% increase from price at the beginning of the year. By the end of this year, you can expect the stock to reach to $305.97 by December 2025 with a 86.99% change.
Johnson & Johnson (JNJ) Stock Price Prediction & Forecast 2026 - 2030
In the next five years, there will be a significant appreciation in the JNJ stock. During this period, the JNJ's price is forecasted to shift from $282.82 to $300.60, which is 6.29% gain.
In 2026, the stock would possibly open at $282.82, escalates to $290.39 by mid-year, and wraps up at $311.34, reflecting a 90.27% increase from today's price. Further moving to 2030, the stock can kick off the year at $334.94, soar to $315.10 by mid-year, and finish at $300.60, which is 83.70% change from current price.
Johnson & Johnson (JNJ) Stock Price Prediction & Forecast 2031 - 2040
During this period, the stock would move from $313.12 to $327.38, which is up 83.65%
In 2031, we can expect JNJ to fluctuate between $300.51 and $313.12, a shift indicating a 83.65% gain by year-end compared to current price. And Until 2040, JNJ can likely vary from $327.38 to $339.41. By the end of 2040, the stock could record a 100.08% rise from today's stock price.
Johnson & Johnson (JNJ) Stock Price Prediction & Forecast 2041 - 2050
According to long-term forecast, the JNJ stock can see an an upturn from $340.69 to $353.45 in this period. In 2041, the stock can experience a low of $313.86 by mid-year, closing the year at $329.70. This results in a 91.81% increase from today.
Moving towards the end of 2050, JNJ is projected to open the year at $370.74. The stock may peak to $385.94 during mid-year and finish the year at $353.45. Compared to the stock's current price, this translates to an overall gain of 116.01% by 2050.
Become a member
Get the latest news right in your inbox. We never spam!
JNJ Competitors
| Ticker | Company | Market Cap | Price | 1m Change | Forecast |
|---|---|---|---|---|---|
| BMY | Bristol-Myers Squibb Company | - | $59.28 | -0.56% ▼ | $58.39 ▲ |
| MRK | Merck & Co., Inc. | - | $87.87 | -3.93% ▼ | $146.41 ▲ |
| ABBV | AbbVie Inc. | - | $210.75 | 0.82% ▲ | $81.29 ▲ |
| NVO | Novo Nordisk A/S | - | $73.60 | -18.81% ▼ | $247.89 ▲ |
| LLY | Eli Lilly and Company | - | $844.27 | 4.09% ▲ | $112.92 ▲ |
Last updated Mar 22 at 7 AM
JNJ : Buy, Sell Or Hold?
Analyst Ratings
Based on 19 analysts, 1 rated as a strong buy, 6 recommended a buy, 12 suggested a hold, 0 advised a sell, and 0 indicated a strong sell.Three months ago, out of 25 analysts, 4 analysts gave a strong buy rating, 8 a buy rating, 13 a hold rating, 0 advised selling, and 0 suggested a strong sell.So, according to analyst ratings, the recommendation for JNJ stock is Hold.Expert Analysis
According to JNJ short-term and long-term forecast, Johnson & Johnson shares are projected to go up by 116.01%, and reach a value of $353.45 per share by 2050.
As per technical analysis, indicators show a Bullish sentiment, while Fear & Greed Index stands at 85.71428571428571, which signals Greed. Also, JNJ has recorded 17/30 green days, which reflects a 73.91304347826086% positivity rate with a price volatility of 0.01%.
Plus, Price-to-Earnings (P/E) ratio of 28.260796 suggests that JNJ stock is overvalued. So, Based on JNJ prediction and analysis, it may be the best time to hold JNJ stock right now.
Disclaimer: Stock predictions, forecasts and price targets provided for "JNJ” are solely for informational and educational purposes and should not be treated as investment or financial advice. Always conduct your own research or consider consulting with a financial advisor before making any investment decisions.